Sign In

Drew Yashar

Associate, Life Sciences, Deep & Frontier Tech @ Capital Factory

Drew Yashar is an Associate at Capital Factory, a prominent venture capital firm based in Texas. He has a strong background in scientific entrepreneurship and life sciences, which he leverages in his role to support early-stage startups.

Professional Background

  • Current Position: As an Associate at Capital Factory, Drew is part of a venture team that focuses on fostering the startup ecosystem in Texas. He transitioned to this role in July 2024, emphasizing his commitment to enhancing the local entrepreneurial landscape.14

  • Previous Experience:

    • Venture Systems Associate at Alix Ventures: Prior to joining Capital Factory, Drew worked at Alix Ventures, a life science fund in San Francisco. His responsibilities included supporting early-stage life science startups and overseeing entrepreneurial fellowship programs at the Innovative Genomics Institute.13
    • Head Editor at BIOS Community: Drew also serves as the head editor for BIOS Community, where he amplifies thought leadership and connects life science professionals.12
    • Angel Investor: He has been involved as an angel investor with various startups, including Endpoint Health and Mythic Therapeutics, focusing on precision immunology and therapeutic advancements.1

Education

Drew Yashar holds a degree from Babson College, where he developed his expertise in entrepreneurship and business development.1

Contributions

Drew is actively engaged in building networks within the life sciences community and has worked on initiatives aimed at translating academic research into marketable solutions. His efforts include collaborating with institutions like UC Berkeley to enhance resources for entrepreneurs in the life sciences sector.12

His work reflects a passion for driving innovation and supporting the next generation of startups in health and science.

Highlights

Jul 26 · linkedin

I am excited to announce my transition to Capital Factory as an associate of our wonderful venture team! The Texas ecosystem has a burgeoning life sciences community with rich sources of capital, clinical, & non dilutive resources which excite me to be fully immersed in this role helping to broaden CF’s rapidly developing Life Sciences portfolio. (Hoping soon to publish my thoughts on the growing Texas space soon - certainly more to come!)

CF prides themselves as the central gravity for entrepreneurs outside of Silicon Valley. To be supported by a veteran team who are excited to further research & innovation, for patient impact, I could be nothing more than excited.   I have learned so much and developed my career in immeasurable ways during my time helping to build Alix Ventures and BIOS. So, to each of you – my colleagues, friends, & mentors – I say Thank YOU! I also hope to release my retrospective thoughts on the immense potential of BIOS and community driven efforts within life sciences vc. We have much to do in this space :)

Thanks again to: Joshua Baer, Bryan Chambers, Jamie Serio, CFA, Nick Spiller, Wynn Lemmons, Lyndon Lay, Audrey Haugh, Jonathan Marcel, among many others!

Learn more about the unique value prop CF brings to the national innovation ecosystem:

Jul 17 · linkedin

🧱 Builders: Kevin Parker - President & CEO, Founder @ Cartography Biosciences

Join us for an exclusive conversation with Kevin Parker, CEO and co-founder of Cartography Biosciences, on our latest podcast episode of BIOS Builders. Kevin delves into his transition from a Ph.D. at Stanford focusing on basic biology to launching a startup aimed at transforming cancer therapy with targeted immunotherapies and an innovative antigen atlas. This episode also explores Cartography Biosciences' recent collaboration with Gilead, highlighting the groundbreaking potential of their partnership in revolutionizing cancer treatment. Learn about the inception of Cartography Biosciences, the development of their transformative technology, and the challenges of navigating the biotech startup landscape amidst a global pandemic. Kevin's insights into the future of precision medicine, the importance of interdisciplinary teams, and the journey towards their first clinical programs offer invaluable lessons for anyone interested in the cutting edge of cancer research and the entrepreneurial journey in life sciences. Don't miss this deep dive into the mission, science, and strategy behind Cartography Biosciences' quest to expand the horizons of cancer treatment.

Tune in: https://buff.ly/4f2OnmH

This episode also explores Cartography Biosciences' recent collaboration with Gilead, highlighting the groundbreaking potential of their partnership in revolutionizing cancer treatment.

Read more about the exciting partnership here: https://buff.ly/4cC0sxo

#BiotechInnovation #PrecisionMedicine #CancerTherapy #StartupJourney #TargetedImmunotherapy #LifeSciences #Entrepreneurship #ClinicalResearch #FutureOfHealthcare #TechBio #BiotechStartup #CancerResearch #InterdisciplinaryTeams #PhDLife #InnovativeTechnology

Related Questions

What are Drew Yashar's main responsibilities at Capital Factory?
How did Drew Yashar contribute to the Innovative Genomics Institute?
What is the BIOS Community, and how does Drew Yashar support it?
What startups has Drew Yashar worked with in the healthcare sector?
How does Drew Yashar's role at Alix Ventures impact early-stage life science startups?
Drew Yashar
Drew Yashar, photo 1
Drew Yashar, photo 2
Add to my network

Location

San Francisco, California, United States